首页|黄连素+四联疗法治疗幽门螺杆菌阳性消化性溃疡的临床效果分析

黄连素+四联疗法治疗幽门螺杆菌阳性消化性溃疡的临床效果分析

扫码查看
目的 探究黄连素(别称:盐酸小檗碱)与四联疗法联合用药方案治疗幽门螺杆菌(Hp)阳性消化性溃疡的临床效果,为临床医师选择合理用药方案提供参考。方法 204 例Hp阳性消化性溃疡患者为研究对象,采用随机数字表法分为对照组和观察组,每组 102 例。对照组患者接受常规四联疗法治疗,观察组采用黄连素与四联疗法联合治疗。比较两组患者症状改善时间、Hp清除率及复发率、临床治疗效果、不良反应发生率。结果 观察组患者反酸、嗳气、腹痛消失时间与溃疡愈合时间分别为(2。95±0。51)、(3。85±0。44)、(5。65±0。88)、(8。74±0。85)d,较对照组的(4。35±0。85)、(6。85±0。61)、(7。51±1。38)、(12。45±1。28)d短(P<0。05)。观察组患者Hp清除率及复发率分别为 96。1%、3。9%,对照组患者分别为 80。4%、17。6%,两组比较,观察组患者Hp清除率高,复发率低(P<0。05)。观察组患者治疗总有效率为 98。0%,对照组为 90。2%,两组比较,观察组较高(P<0。05)。观察组患者不良反应发生率为2。0%(2/102),与对照组的 3。9%(4/102)比较无差异(P>0。05)。结论 对Hp阳性消化性溃疡患者实施四联疗法治疗时联合黄连素可以快速改善临床症状,提升治疗效果,同时还能提高Hp清除率,降低复发率,值得推广。
Analysis of clinical effect of berberine plus quadruple therapy on Helicobacter pylori-positive peptic ulcer
Objective To investigate the clinical effect of berberine hydrochloride(alternative name:berberine)combined with quadruple therapy in the treatment of Helicobacter pylori(Hp)-positive peptic ulcer,so as to provide reference for clinicians to choose a rational drug regimen.Methods A total of 204 patients with Hp-positive peptic ulcer were selected as the research subjects.They were divided into a control group and an observation group by random table method,each included 102 samples.The control group received conventional quadruple therapy,while the observation group received a combination of berberine and quadruple therapy.The symptom improvement time,Hp clearance rate and recurrence rate,clinical therapeutic effect and incidence of adverse reactions were compared between the two groups.Results In the observation group,the disappearance time of acid reflux,belching and abdominal pain and the ulcer healing time were(2.95±0.51),(3.85±0.44),(5.65±0.88)and(8.74±0.85)d,which shorter than(4.35±0.85),(6.85±0.61),(7.51±1.38)and(12.45±1.28)d in the control group(P<0.05).The Hp clearance rate and recurrence rate were 96.1%and 3.9%in the observation group,and 80.4%and 17.6%in the control group;comparing the two groups,the patients in the observation group had a higher Hp clearance rate and a lower recurrence rate(P<0.05).The total effective rate of treatment in the observation group was 98.0%,and that in the control group was 90.2%;comparing the two groups,the observation group was higher(P<0.05).The incidence rate of adverse reactions in the observation group was 2.0%(2/102),and there was no difference compared with 3.9%(4/102)in the control group(P>0.05).Conclusion Application of quadruple therapy combined with berberine in patients with Hp-positive peptic ulcer can rapidly improve clinical symptoms,enhance the therapeutic effect,and at the same time improve the Hp clearance rate and lower the recurrence rate,which is worthy of promotion.

Helicobacter pyloriPeptic ulcerBerberineQuadruple therapyDrug combinationClinical efficacy

李毅、李坚

展开 >

110866 沈阳农业大学医院

110002 沈阳医学院附属第二医院·辽宁省退役军人总医院药剂科

幽门螺杆菌 消化性溃疡 黄连素 四联疗法 联合用药 临床疗效

2024

中国现代药物应用
中国水利电力医学科学技术学会

中国现代药物应用

影响因子:0.862
ISSN:1673-9523
年,卷(期):2024.18(15)